Skip to main content

Table 4 Treatment response between GCB subgroup and non-GCB subgroups in HBsAg-positive and -negative DLBCL patients

From: Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China

Treatment response

HBsAg-positive patients

HBsAg-negative patients

GCB (n = 47)

non-GCB (n = 79)

P-Value

GCB (n = 107)

non-GCB (n = 186)

P value

CR/CRu

42

46

0.252

73

123

0.718

PR

15

27

 

29

54

 

SD

0

1

 

2

2

 

PD

3

5

 

3

7

 
  1. CR complete response, PR partial response, SD stable disease, PD progressive disease